(119) distinguished isocitrate dehydrogenase mutation status in gliomas by a fully automated approach combining radiomics and deep learning, obtaining 93.8%, 87.9%, and 78.8% accuracy in-house in the Seoul National University Hospital and The Cancer Imaging Archive datasets, respectively. Here, IDH3A is linked to central nervous system cancer.